Analysis: Little to fear for Fresenius in U.S. health spending cuts

The headquarters of Fresenius is pictured in Bad Homburg near FrankfurtFRANKFURT (Reuters) – Fresenius Medical Care's focus on a life-threatening illness and its buying power with suppliers mean the world's biggest kidney dialysis provider may cope better with cuts in U.S. healthcare spending than many investors think. FMC's shares have slumped about 10 percent over the past three months on expectation the United States, battling to rein in its budget deficit, will reduce funds for state-run health schemes like Medicare that account for about 30 percent of the German company's revenues. …

Aetna profit falls on costs and legal settlement

(Reuters) – Aetna Inc said on Thursday that fourth-quarter earnings fell sharply, as costs rose in parts of its employer-based insurance business and it took charges for settling litigation over payment practices for out-of-network care. The health insurer also said Chief Financial Officer Joseph Zubretsky would lead a new business internally. Shawn Guertin, who has been with Aetna since 2011 and was previously CFO of Coventry Health Care Inc , which Aetna is buying, will replace Zubretsky on February 25. The Hartford, Connecticut company announced plans in August for the $5. …

Long-delayed school snack rules to come soon: Vilsack

Students have a nutrition break mid-morningl at Belmont High School in Los AngelesWASHINGTON (Reuters) – After more than a year's delay, American schools will soon see new U.S. government rules targeting the kinds of snacks sold to students, a move nutritionists say could play an important role in fighting childhood obesity. Anxious schools have waited more than a year to find out how sales of potato chips, candy bars, sodas and similar treats to students will be restricted. These rules on food sold outside traditional cafeteria meals are a key part of the first major overhaul on school food in more than three decades. …

Celsion’s liver cancer therapy fails to meet late-stage trial goal

(Reuters) – Celsion Corp said a late-stage study of its experimental liver cancer treatment ThermoDox did not meet the main goal of increasing patients’ survival without their cancer worsening. The study, named HEAT, was designed to show a 33 percent improvement in progression-free survival, Celsion said in a statement. Celsion CEO Michael Tardugno said the company is conducting additional analyses of data from the trial to assess the future strategic value of ThermoDox. (Reporting By Pallavi Ail in Bangalore; Editing by Roshni Menon)

UK study strengthens link between GSK flu shot and narcolepsy

LONDON (Reuters) – Children in Britain who were vaccinated with a GlaxoSmithKline shot against H1N1 swine flu had a significantly increased risk of developing the rare sleep disorder narcolepsy, according to results of a scientific study. The findings, which have not yet been published in full, are the first firm evidence in Britain that the flu vaccine, called Pandemrix, is linked to narcolepsy cases in children. Research in Finland, Sweden and Ireland has already found clear associations and Reuters reported last week that similar links were expected to be found in Britain. …

U.S. porn star Ron Jeremy resting after aneurysm surgery

File photo of Ron Jeremy in Park CityLOS ANGELES (Reuters) – Veteran pornography actor Ron Jeremy, one of the industry's biggest stars, was resting after undergoing surgery in Los Angeles on Wednesday for an aneurysm near his heart, his manager said. Jeremy, 59, who appeared in more than 2,000 adult films, drove himself to Cedars-Sinai Medical Center in Los Angeles early on Wednesday after suffering from chest pains. "He just felt chest pains, like a very heavy weight," Jeremy's manager Mike Esterman said. "He is being worked on for an aneurysm near his heart. …

1 886 887 888 889 890 977